Senologie - Zeitschrift für Mammadiagnostik und -therapie 2020; 17(04): 232-235
Empfehlungen der Österreichischen
Gesellschaft für Senologie – Nachsorge nach Mammakarzinom
Michael Stierer
1
PK Döbling, Brustzentrum Wien, Vorstandsmitglied der ÖGS
,
Rupert Bartsch
2
Medizinische Universität Wien, Universitätsklinik für Innere Medizin 1, Klinische
Abteilung für Onkologie, Mitglied des wissenschaftlichen Beirats der ÖGS
› Author Affiliations
Literatur
1
Early Breast Cancer Trialists Collaborative Group (EBCTCG).
Effects of chemotherapy and Hormonal therapy for early breast cancer recurrence and
15 year survival: an overview of the randomized trials. Lancet 2005; 365: 1687 2
Grunfeld E.
et al. Randomized trial of long-term follow-up for early stage breast cancer: A comparision
of family physician versus specialist care. J Clin Oncol 2006; 24: 848 3
Runowicz CD.
et al. American Cancer Society/American Society of Clinical Oncology breast cancer
survivorship care guideline. J Clin Oncol 2016; 34: 611 4
Houssami N,
Ciatto S.
Mammographic surveillance in women with a personal history of breast cancer: how accurate?
How effective?. Breast 2010; 19: 439 5
Ribelles N.
et al. Pattern of recurrence of early breast cancer is different according to intrinsic
subtype and proliferation index. Breast Cancer Res 2013; R98: 15 6
Goldhirsch A.
et al. Progress and promise: highlights of the international expert consensus on the
primary therapy of early breast cancer. Ann Oncol 2007; 18: 1133 7
Perou CM.
et al. Molecular portraits of human breast tumors. Nature 2000; 406: 747 8
Cheang MCH.
et al. KI 67 Index, Her2 Status and prognosis of patients with luminal B breast cancer.
J Natl Cancer Inst 2009; 101: 736 9
Winchester D.
et al. Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer
1979; 43: 956 10
Kubista E.
et al. Empfehlungen zur Nachsorge nach Mammakarzinom. Senologie 2007; 3: 158 11 AGO Guidelines Breast Version 2018. www.ago-online.de 12
Bich U,
Helbich T.
Follow-up of patient with breast cancer: Imaging of local recurrence and distatant
metastases. In:
Hodler H.
et al. (eds.) Diseases of the Chest, Breast, Heart and Vessels 2019–2022. IDKD Springer
Series; 13
Saslow D.
et al. American Cancer Society guidelines for breast screening with MRI as an adjunct
to mammography. CA Cancer J Clin 2007; 57: 75 14
Nemanic S.
et al. Comparison of thoracic radiographs and single breat-hold helical CT for detection
fo pulmonary nodules in dogs with metastatic neoplasia. J Vet Intern Med 2006; 20:
508 15
Yoon JH,
Kim MJ,
Kim EK.
et al. Imaging surveillance of patients with breast cancer after primary treatment:
current recommendations. KJR 2015; 16: 219-228 16
Moy L,
Bailey L,
D’Orsi C.
et al. ACR appropriateness criteria stage I breast cancer: initial workup and surveillance
for local recurrence and distant metastases in asymptomatic women. J AmColl Radiol
2017; 14: S282-S292 17 NCCN Guidelines Breast Cancer version 4.2018. www.nccn.org 18
GIVIO Investigators.
Impact of follow-up and testing on survival and health-related quality of life in
breast cancer patients: a multicenter randomized controlled trial. JAMA 1994; 271:
1587 19
Roselli Del Turco M.
et al. Intensive diagnostic follow-up after treatment of primary breast cancer: A
randomized trial. JAMA 1994; 271: 1593 20
Vlastos G.
et al. Long-term survival after an aggressive surgical approach in patients with breast
cancer hepatic metastases. Ann Surg Oncol 2004; 11: 869 21
Rolle A.
et al. Is surgery for multiple lung metastases reasonable? A total of 328 consecutive
patients with multiple laser metastasectomies with a new 1318-mm Nd: YAG laser. J
Thorac Cardiovasc Surg 2006; 131: 1236 22
Chua TC.
et al. Hepatic resection for metastatic breast cancer: A systematic review. Eur J
Cancer 2011; 47: 2282 23
Stierer M.
Evidence-based follow-up for breast cancer. short review memo 2020; 13: 60
